What is a stock summary page? Click here for an overview.
Business Description
Tianda Pharmaceuticals Ltd
ISIN : KYG887471038
Compare
Compare
Traded in other countries / regions
00455.Hong Kong IPO Date
1992-03-30Description
Tianda Pharmaceuticals Ltd is engaged in R&D, manufacturing, and sales of pharmaceutical, biotechnology, and healthcare products, and investment in the development of the Chinese medicine industry. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include the Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives the majority of its revenue from the Pharmaceuticals and medical technologies business.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.99 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -2.45 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.37 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | -25.6 | |||||
| 3-Year FCF Growth Rate | 1.8 | |||||
| 3-Year Book Growth Rate | -6.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.26 | |||||
| 9-Day RSI | 53.83 | |||||
| 14-Day RSI | 52.85 | |||||
| 3-1 Month Momentum % | 0.59 | |||||
| 6-1 Month Momentum % | -18.66 | |||||
| 12-1 Month Momentum % | -34.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | |||||
| Quick Ratio | 0.67 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 120.01 | |||||
| Days Sales Outstanding | 76.91 | |||||
| Days Payable | 172.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.44 | |||||
| 3-Year Dividend Growth Rate | 44.2 | |||||
| Forward Dividend Yield % | 1.44 | |||||
| 5-Year Yield-on-Cost % | 0.78 | |||||
| Shareholder Yield % | 8.84 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.83 | |||||
| Operating Margin % | -11.07 | |||||
| Net Margin % | -12.29 | |||||
| FCF Margin % | -17.64 | |||||
| ROE % | -8.16 | |||||
| ROA % | -5.27 | |||||
| ROIC % | -6.08 | |||||
| 3-Year ROIIC % | -16.81 | |||||
| ROC (Joel Greenblatt) % | -9.95 | |||||
| ROCE % | -6.68 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.01 | |||||
| PB Ratio | 0.72 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -9.59 | |||||
| EV-to-EBITDA | -9.59 | |||||
| EV-to-Revenue | 1.01 | |||||
| EV-to-FCF | -5.71 | |||||
| Price-to-GF-Value | 0.75 | |||||
| Price-to-Median-PS-Value | 0.53 | |||||
| Earnings Yield (Greenblatt) % | -10.43 | |||||
| FCF Yield % | -17.54 | |||||
| Forward Rate of Return (Yacktman) % | 21.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tianda Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 384.678 | ||
| EPS (TTM) (HK$) | -0.022 | ||
| Beta | 0.07 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.36 | ||
| Volatility % | 33.71 | ||
| 14-Day RSI | 52.85 | ||
| 14-Day ATR (HK$) | 0.005485 | ||
| 20-Day SMA (HK$) | 0.1749 | ||
| 12-1 Month Momentum % | -34.62 | ||
| 52-Week Range (HK$) | 0.155 - 0.275 | ||
| Shares Outstanding (Mil) | 2,150.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tianda Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tianda Pharmaceuticals Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tianda Pharmaceuticals Ltd Frequently Asked Questions
What is Tianda Pharmaceuticals Ltd(HKSE:00455)'s stock price today?
The current price of HKSE:00455 is HK$0.18. The 52 week high of HKSE:00455 is HK$0.28 and 52 week low is HK$0.16.
When is next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455)?
The next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455) is .
Does Tianda Pharmaceuticals Ltd(HKSE:00455) pay dividends? If so, how much?
The Dividend Yield %  of Tianda Pharmaceuticals Ltd(HKSE:00455) is 1.44% (As of Today), Highest Dividend Payout Ratio of Tianda Pharmaceuticals Ltd(HKSE:00455) was 3. The lowest was 0.31. And the median was 1. The  Forward Dividend Yield % of Tianda Pharmaceuticals Ltd(HKSE:00455) is 1.44%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers